Home Blog Page 618

Colgate Optic White® Partners with Tsim Sha Tsui Cafe to Launch “Dental-Grade Teeth Whitening Lab”

By
Advertorial Desk
-

Canto-pop Star Kaho Hung Joins as “One-Day Store Manager” to Champion the Aesthetic of “Drink Boldly, Smile Brightly”

Unlock the Secret to a “Zero-Distance” Dental-Grade Bright Smile with Hydrogen Peroxide (HP) – Hong Kong Dentists’ Most Preferred Whitening Ingredient^

HONG KONG, April 9, 2026 /PRNewswire/ — For the modern urbanite who values quality of life, coffee is more than just a beverage; it is the ritualistic start to a quality lifestyle. Whether it is a rejuvenating morning black coffee or an afternoon latte with friends, coffee moments are essential for “charging” one’s day. However, for coffee lovers, the lingering concern of dark, stubborn extrinsic stains and teeth yellowness often dims the experience. As the authority in professional teeth whitening, Colgate Optic White®—Hong Kong’s No.1 Whitening Toothpaste Brand^^—is proud to unveil the secret to a professional-grade bright smile. Optic White® Whitening Toothpaste Series is formulated with Hydrogen Peroxide (HP), Hong Kong Dentists’ Most Preferred Whitening Ingredient^. Unlike traditional toothpastes that only tackle surface stains, HP penetrates deep into the enamel to break down years of dark, stubborn extrinsic stains from the inside out, while creating a long-lasting protective barrier against new stains. By simply integrating this into a daily oral care routine, coffee enthusiasts can indulge in their favorite brews without compromise, showcasing a confident, bright and “zero-distance” smile.


From 11th April to 11th May, 2026, Colgate is breaking boundaries by transforming the popular Tsim Sha Tsui cafe, HOW to Live Well, into Colgate Optic White® Dental-Grade Teeth Whitening Lab. This immersive pop-up aims to educate the public on the science of professional teeth whitening, revealing why Hydrogen Peroxide (HP) is the gold standard for achieving a dental-grade transformation. Adding to the excitement, Colgate has invited sensational Canto-pop singer and fan-favorite “Dean,” Kaho Hung, to make a special appearance as the “One-Day Store Manager” on 18th April, 2026. Known for his signature “zero-distance” bright smile, Kaho will lead guests through a sensory journey of coffee and professional whitening excellence, sharing how he maintains a camera-ready, bright smile amidst his hectic schedule using this dentist-preferred whitening solution.

“Drink Boldly, Smile Brightly”: Master the Art of Coffee Living with the Hong Kong Dentists’ Most Preferred Whitening Ingredient^ – Hydrogen Peroxide (HP)

For a connoisseur like Kaho Hung, coffee and a bright smile are the ultimate lifestyle duo. During the event, Kaho will personally craft the Colgate Optic White® signature special (White Cloud Apple Jasmine Brew)—a bespoke coffee featuring cocoa-dusted Optic White® motifs on creamy foam in Dental-Grade Teeth Whitening Lab. To elevate the experience, the drink is served with a creative Minty Cream “toothpaste tube”, allowing shoppers to simulate the Colgate Optic White® whitening process by adding their own minty cream to their coffee. This aesthetic experiment embodies Kaho’s lifestyle motto: “Drink Boldly, Smile Brightly”—a reminder that with the right professional care —Colgate Optic White® and its Hong Kong Dentists’ Most Preferred Whitening Ingredient^—Hydrogen Peroxide (HP), you never have to choose between your passion for coffee and a bright smile.

Limited Time Only! An Immersive Journey Where Specialty Coffee Meets Professional Teeth Whitening

Colgate Optic White® Dental-Grade Teeth Whitening Lab is more than just a cafe; it is an immersive space where professional dental whitening science meets lifestyle chic. Every detail, from the minimalist decor to the curated displays, reflects Colgate’s professional authority and reinforces the professional reliability of Hydrogen Peroxide (HP), the Hong Kong Dentists’ Most Preferred Whitening Ingredient^.

Visitors can interact with a specially designed “Smile Phone” installation. Equipped with a high-definition camera, the device allows fans to capture their own Kaho-inspired bright smiles. Visitors can also record heartfelt voice messages for the “Dean” himself, creating a warm, interactive and personalized connection within this professional-yet-inviting space.

Optic White® Dental-Grade Teeth Whitening Lab: A Month of Sensory Surprises and Exclusive Dental-Grade Rewards

Beyond showcasing its professional authority, the Colgate Optic White® Dental-Grade Teeth Whitening Lab offers exclusive and professional-grade rewards to bring professional care into every home. With any beverage purchase at the café, shoppers will receive an exclusive discount voucher for Colgate Optic White® designated whitening toothpastes—the series formulated with Hydrogen Peroxide (HP), the Hong Kong Dentists’ Most Preferred Whitening Ingredient^. This voucher is redeemable at all major physical stores and online shops. For those with the purchase of the signature special (White Cloud Apple Jasmine Brew), a further premium reward awaits: a complimentary tube of Colgate Optic White® Pro Series Whitening Toothpaste, featuring a 5% Hydrogen Peroxide (HP) concentration (Valued HK$119.9). Through these exclusive rewards, Colgate ensures your journey to a dental-grade bright smile continues long after your coffee break.

Event Information
Colgate Optic White® Dental-Grade Teeth Whitening Lab
Date: 11th April, 2026 (Saturday) – 11th May, 2026 (Monday)
Venue: HOW to Live Well
Venue address: Shop 201-01, 2/F, K11 Art Mall, 18 Hanoi Road, Tsim Sha Tsui, Hong Kong

Colgate X Kaho Hung: “One-Day Store Manager” at Optic White® Dental-Grade Teeth Whitening Lab
Date: 18th April, 2026 (Saturday)
Time: 11:00 AM – 2:00 PM
Venue: HOW to Live Well
Venue address: Shop 201-01, 2/F, K11 Art Mall, 18 Hanoi Road, Tsim Sha Tsui, Hong Kong

Product Information

Colgate Optic White® Whitening Toothpaste Series

  •  Formulated with Hydrogen Peroxide (HP) – Hong Kong Dentists’ Most Preferred Whitening Ingredient^
  •  Effectively remove 256% of intrinsic stain*
  •  12 hours of stain prevention 174%+

Explore more at: https://youtu.be/5jXIJnCtwTU

Available at the physical stores and online shops of the following retailers:

For more high-resolution images, please visit the link: 
https://drive.google.com/drive/folders/1Eln3NsKAKb4UuXT_QHT_nMIDu-KYj1pJ?usp=sharing

Tags & Hashtags:
@colgate.hongkong
#Colgate #ColgateHK #OpticWhite #ColgateSmile #WhiteningToothpaste #HungKaho #One-DayStoreManager #DentalGradeTeethWhiteningLab

About Colgate-Palmolive
Colgate-Palmolive is a global leader in household and personal care products, offering a wide range of products in oral care, personal care, home care, and pet nutrition. Colgate’s well-known brands are sold in over 200 countries and regions worldwide, including Colgate, Palmolive, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Sanex, Ajax, Axion, Soupline, Suavitel, Hill’s Science Diet, Hill’s Prescription Diet, and Hill’s Ideal Balance.

^Based on the 2025 Hong Kong International Dental Expo And Symposium (HKIDEAS) survey, Hydrogen Peroxide (HP) is the top-ranked whitening ingredient preferred by the majority of responding dentists, dental therapists, and dental hygienists. The concentration of HP in Colgate’s whitening toothpaste differs from the actual concentration used in clinical settings
^^Colgate calculation based in part on data reported by NielsenIQ through its Retail Index Service for the defined Whitening segment of Toothpaste category for the 1-year period ending December 2024, for Total Supermarkets, CVS and Drug Stores in Hong Kong. (Copyright © 2025, NielsenIQ)
*Referring to Colgate Optic White Platinum Series Stainless and Express White Toothpaste. Compared to Colgate regular fluoride toothpaste. Brush twice daily, whitening results of 3 days
+Referring to Colgate Optic White Pro Series Hydrogen Peroxide 5% Whitening Toothpaste, based on the laboratory efficacy study vs. Colgate regular fluoride toothpaste

e-Bike Innovator Avinox Powers the Next Generation of Electric Bikes with the Launch of the Avinox M2S and Avinox M2 with 60 Leading Bike Brands

By
Advertorial Desk
-

New Avinox Batteries Introduced for the First Time, Further Enabling Users to Customize their Ride

SHENZHEN, China, April 9, 2026 /PRNewswire/ — Avinox, the e-bike innovator behind the award-winning Avinox M1 e-bike drive system, today launches the Avinox M2S and Avinox M2, the next evolution of Avinox drive systems offering unmatched power, control, range, and efficiency. Over 60 industry partners have integrated the newest Avinox systems, including Amflow, Atherton, BH, Canyon, Commencal, Crestline, Crussis, Forbidden, Megamo, Mondraker, Pivot, Propain, Raymon, Rotwild, Steppenwolf, Teewing, Thömus, Unno, Whyte and more.

e-Bike Innovator Avinox Powers the Next Generation of Electric Bikes with the Launch of the Avinox M2S and Avinox M2 with 60 Leading Bike Brands
e-Bike Innovator Avinox Powers the Next Generation of Electric Bikes with the Launch of the Avinox M2S and Avinox M2 with 60 Leading Bike Brands

“Avinox continues to expand its market presence with innovations like today’s new drive systems,” said Ferdinand Wolf, Product Experience Director at Avinox. “Our established independence as a company has only elevated and accelerated Avinox’s commitment to excellence and industry leadership, and we look forward to bringing positive changes to the status quo with new products that propel the industry forward. Since the launch of the Avinox M1 in 2024, we have garnered substantial support and popularity among manufacturers and users. As of today’s announcement, Avinox has the privilege of working with more than 60 top OEM bike brand partners, and we’re thrilled to have them along with us on the journey to change the world of e-bikes.”

Lightweight & Compact Unit

One of the most celebrated features of the Avinox M1 is its compact size and featherlight weight. Both the Avinox M2S and M2 maintain the M1’s small form factor almost exactly, with each weighing approximately 2.59 kg and 2.65 kg[1], respectively. The M2S offers a 45% increase in power density and a 21.6% increase in torque density[1] compared to the Avinox M1 Drive Unit, while the M2 delivers a 4.6% increase in power density.[1]

Higher Power & Torque, Quieter and Cooler Ride

Avinox continues to redefine the limits of power in e-bikes. The new high-performance Avinox M2S motor introduces a peak power limit of 1,500W and 150Nm of peak torque and 130Nm of continuous torque[1], delivering high power and smooth, rider-controlled assistance, while the Avinox M2 motor also promises a powerful ride, with a peak power limit of 1,100W and 125Nm of peak torque[1].

Despite the increased power, noise is kept to a minimum, with the drive systems operating with a sound pressure level of ≤ 45 dBA.[1] The Avinox M2S eliminates gear play and pedal kickback noise with a dual-gear meshing design, and the Avinox M2 uses helical gears to reduce knocking or rattling sounds, even on rough terrain.

The new-generation Avinox M2S Drive Unit also integrates a temperature sensor, paired with all-new cooling fins and flat wire windings. This significantly boosts heat dissipation and reduces energy loss, ensuring stable and sustained high-power output.

Ample Battery Power to Extend Range

The company’s latest integrated battery, the custom Avinox FP700 is a 700Wh high-energy battery that unleashes the motor’s full potential, easily handling long-distance rides. With a weight of 3.18 kg and an energy density of 220 Wh/kg, the Avinox FP700 also supports GaN 3x fast charging for efficient power replenishment, charging from 0% to 80% in 1 hour and 16 minutes[1].

Today’s launch also includes Avinox’s first removable batteries: the Avinox RS800 and the Avinox RS600. Whether a rider is commuting or exploring on long-distance rides, the batteries can be easily removed for charging with a simple quick-release feature, offering the option to charge the battery without moving the entire bike to an outlet. The Avinox RS800 Battery boasts a high energy density of 200 Wh/kg, weighs only about 4 kg, and delivers 800 Wh of energy, while the Avinox RS600 delivers 600 Wh of energy and weighs just about 2.96 kg,[1] making it suitable for short daily rides.

The Avinox RS600 Battery can also be mounted externally on a bike frame to serve as a dual battery, significantly extending how far and long cyclists can ride and eliminating the fear of running out of battery on a ride.

Control and Guidance, At a Glance

Avinox is also introducing two new display control screens: the Avinox DP100-F and the DPC100. These 2-inch OLED full-color control displays guarantee performance, even during wet weather and on muddy routes. New features include:

  • Ride navigation: Riders can import routes from third-party route-planning apps to the Avinox Ride App, and they’ll be sent to the control display, which will provide turn-by-turn directions and alerts throughout the ride. The route can be saved on the display to use again.
  • Heart rate-based range adjustments: Riders can pair a heart rate monitor, set a target heart rate range, and the level of assist output will adjust to keep the rider’s heart rate within the set range. If the heart rate spikes above the range, the motor will increase assist to help the rider reduce exertion, and if the heart rate is low, the motor will decrease assist so that the rider has to increase their own effort and output.
  • Integration with the Apple Find My[1] ecosystem: After binding the bike to Apple’s Find My app, users can check the bike’s location and battery level, or trigger a sound to locate it anytime (only available with the DPC100 Display).

Avinox Ride App

The latest version of the Avinox Ride App offers users even more control from their phone, including new features such as:

  • Custom riding parameters: Based on riding preferences and scenarios, riders can use the Avinox Ride app to adjust riding parameters such as assist level, start assist, continued assist, and max torque, creating a unique riding style. The data layout on the control display can also be customized to adjust parameter visuals, satisfying personalized data viewing needs.
  • Health Management System (HMS): When detecting a malfunction in the drive system, an alert will be shown on the control display and a beep will sound to notify riders. Any error status can be checked, troubleshot, and resolved via app.
  • Abnormal Movement Alerts: When pairing the bike with a phone via Bluetooth, users can enable the Bluetooth unlock feature to automatically unlock the bike upon approach. Also, the app’s Bike Protection features can send the user a notification in the event of an abnormal bike movement.

Avinox Ultimate Connectivity

The Avinox systems have been designed for interoperability, allowing the use of key Avinox components across different Avinox models. The new generation motors, batteries, and touchscreens are compatible and interchangeable with those of the previous generation, and vice versa.

Availability

For potential business partnership, please contact: sales@avinox-ebike.com
For more information, please visit www.avinox-ebike.com.

Certified Quality and Global Support

The Avinox Drive System’s components have been rigorously tested and certified by authoritative organizations such as TÜV SÜD and TÜV Rheinland[1]. Avinox’s global network of over 20 service centers ensures that riders have access to timely and professional support.

[1] All data was tested in controlled conditions. Actual experience may vary. For more details, please refer to www.avinox-ebike.com.

 

About Avinox

Avinox is an e-bike systems company building integrated technology that powers the next generation of electric bicycles. The innovator behind the award-winning Avinox e-bike drive system, the company develops drive systems and products that work together to deliver a natural and responsive riding experience. Avinox represents a new generation of e-bike system providers, focused on seamless integration, efficiency, and digital capability led by cutting-edge technology and thoughtful design. With an unwavering commitment to technological excellence and uncompromising performance, Avinox challenges the industry standard and redefines how an e-bike is built. Leading bike manufacturers across the globe have embraced the company’s vision and partnered with Avinox to shape the future of electric mobility.

For more information, please visit our:

Website: www.avinox-ebike.com
Instagram: https://www.instagram.com/avinoxebike
Facebook: https://www.facebook.com/avinoxebike
YouTube: https://www.youtube.com/@AvinoxeBike

ISCA Academy Launches Hands-On AI Programme Across ASEAN to Close Finance Skills Gap

By
Advertorial Desk
-

New initiative equips finance, audit and accounting professionals with immediately applicable AI skill from Excel automation to AI agents as demand for practical AI capability accelerates across the region


SINGAPORE – Media OutReach Newswire – 9 April 2026 – As artificial intelligence (AI) rapidly shifts from experimentation to everyday business use, the Institute of Singapore Chartered Accountants (ISCA) Academy has launched a hands-on AI training programme across ASEAN to address the region’s growing skills gap in finance and accounting.

Designed for immediate workplace application, the new programme equips finance, audit, and accounting professionals with practical AI capabilities, from automating Excel workflows and extracting data from documents to building dashboards, generating presentations, and deploying AI agents to support complex processes.

Developed in partnership with Singapore-based AI training specialist Skybots, the programme focuses on real-world tasks using widely accessible tools such as Microsoft Copilot, enabling participants to deliver tangible productivity gains from day one.

Leveraging ISCA’s network of overseas offices, the initiative will be rolled out across key ASEAN markets including Malaysia, Vietnam, Indonesia, Thailand and the Philippines, with an initial target to train 2,500 finance professionals in the first phase, positioning Singapore as a regional hub for applied AI capability in finance.

Ms Cyndi Pei, Chairperson of ISCA Academy, said the programme represents a strategic response to a rapidly evolving profession: “The window for treating AI as a theoretical topic is closing. Finance professionals across ASEAN are now expected to apply AI in their daily work — safely, effectively, and immediately. ISCA Academy is stepping up to lead this transformation regionally, ensuring professionals across Southeast Asia have access to practical training that delivers real outcomes, not just awareness.”

Immediate Impact in the Workplace

Unlike traditional AI programmes that focus on concepts, ISCA Academy’s approach is fully task-based. Participants work on real scenarios such as financial analysis, document review, reporting, and workflow automation, producing outputs they can directly replicate in their roles. Across pilot sessions, participants have reported completing tasks in minutes that previously took hours, a shift that compounds quickly across teams and reporting cycles.

A key differentiator is its emphasis on responsible AI use, embedding considerations of confidentiality, ethics, compliance, and governance into every module, which are critical for regulated professions.

Early pilot sessions have demonstrated measurable impact. Dr Jenny Tan, Head of Group Internal Audit at CapitaLand, noted: “What stood out about the Practical AI programme was how hands-on and relevant it was. Rather than focusing on theory, our staff came away with techniques they could use from day one and we have observed a real shift in how our team approaches their daily work.”

Built for Mainstream Professionals

The programme is designed for broad accessibility, requiring no coding knowledge or significant technology investment. Participants learn to leverage free and low-cost AI tools to enhance productivity and output quality.

Mr Daryl Aw, Founder and Director of Skybots, who brings a unique background as both a Chartered Accountant and three-time UiPath Most Valuable Professional (MVP), said the programme demystifies AI for finance professionals: “There is a common misconception that AI requires technical expertise or large budgets. In reality, the tools are already available. What professionals need is the confidence and practical know-how to apply them effectively and responsibly. This programme is built to deliver exactly that.”

Regional Rollout and Expansion

The first phase of the programme launches in mid-April, focusing on audit, accounting and finance professionals across the private sector, public sector and charities. A second phase in the third quarter will expand coverage to additional sectors including tax, corporate secretarial, human resources, banking and finance, and legal.

Through its regional network, ISCA Academy aims to train finance professionals across ASEAN and support broader efforts to accelerate digital upskilling and strengthen workforce competitiveness.

A Broader Shift Across Industries

The initiative reflects a wider transformation across ASEAN, where AI adoption is expanding beyond technology teams into core business functions. Finance, public sector, and corporate professionals are increasingly using AI for practical applications such as extracting insights from unstructured data, streamlining compliance workflows including KYC and AML checks, and automating reporting processes.

The message from ISCA Academy and Skybots is consistent: meaningful AI adoption does not require large budgets or deep technical expertise. With the right training, professionals across ASEAN can begin generating real value from AI from day one.

Hashtag: #ISCA #DifferenceMakers #Accounting #Accountancy #CharteredAccountants #ChooseAccountancy #AI #ArtificialIntelligence

The issuer is solely responsible for the content of this announcement.

Institute of Singapore Chartered Accountants (ISCA) Academy

The Institute of Singapore Chartered Accountants (ISCA) is the national accountancy body of Singapore. Established in 1963, ISCA administers the Singapore Chartered Accountant Qualification programme and is the designated entity by the Singapore Ministry of Finance to confer the Chartered Accountant of Singapore [CA (Singapore)] designation.

ISCA supports over 43,000 members across industries in Singapore and globally, with members in more than 40 countries. With a growing international presence, ISCA has 12 overseas chapters, 7 offices across 10 countries and a network of over 150 strategic partners, strengthening professional connections and opportunities across borders. ISCA is also a member of Chartered Accountants Worldwide, a global network representing more than 1.8 million Chartered Accountants and students across over 190 countries.

ISCA advances professional development and lifelong learning through ISCA Academy, its training arm and drives community impact through ISCA Cares, its charity arm.

ISCA Academy, the leading business school of ISCA, delivers immersive, industry-informed learning across accountancy, finance, technology, governance, and leadership. We equip learners to reskill, reconnect, and reinvent – empowering them to stay relevant and ahead by choice.

For more information, visit .

Skybots Pte Ltd

Skybots is a Singapore-based specialist in practical AI training and automation solutions, serving organisations across the public and private sectors. The firm has a particularly strong presence in the finance and accounting community, working closely with finance, accounting, audit, tax and corporate secretarial professionals to apply AI to real workplace tasks. Founded by Daryl Aw, a Chartered Accountant (CA) under ISCA and three-time UiPath Most Valuable Professional (MVP), Skybots designs and delivers hands-on programmes that equip professionals with immediately applicable skills — without requiring technical backgrounds or large technology budgets.

Skybots serves clients across Singapore and internationally, with training delivered in Australia, New Zealand, Malaysia, Indonesia and Bhutan. It is a recognised training partner of ISCA and sits on ISCA’s AI Solutions Sub-Committee.

For more information, visit .

Ragnarok: Twilight Global Limited-Time CBT Now Live! Transform into Heroes and Experience the Brand-New RO!

By
Advertorial Desk
-

NEW YORK, April 9, 2026 /PRNewswire/ — Ragnarok: Twilight Global, a new MMORPG in the Ragnarok series released by Gravity Game Vision, has officially announced an Android Closed Beta Test (CBT) across multiple regions, including Europe and North America. The game has already launched in several Asian regions and achieved the NO.1 free game on both App Store and Google Play Store in multiple markets. This CBT will take place from April 9 to April 16. Blending classic RO elements with innovations, players can experience exclusive gameplay features such as「100% MVP Gear Drops」and「MVP Hero Transformation」. Players can transform into legendary MVP monsters like Baphomet to turn the tide of battle and experience an improved combat system.

Ragnarok: Twilight Global "Loot all right, Heroes unite!"
Ragnarok: Twilight Global “Loot all right, Heroes unite!”

Famous IP Reborn, Nostalgia Meets Innovation

This game perfectly recreates the iconic elements of Ragnarok Online, preserving its beloved BGM, adorable pets such as Poring and Lunatic, as well as a rich and versatile fashion system. Meanwhile, this game also faithfully restores RO’s job transition system, allowing players to progress from Novice to「Swordsman」, 「Acolyte」, 「Mage」, 「Thief」,「Archer」and more, with additional gameplay through first and second job changes.

100% MVP Gear Drops, Easy Leveling Even While Offline

The most relaxed RO experience is here! No need to purchase equipment—defeat MVPs and enjoy a 100% gear drop! Even when offline, you can still level up automatically and accumulate up to 20 hours of offline rewards, allowing you to earn valuable resources effortlessly. Rare cards and epic equipment can be obtained simply by defeating monsters, ensuring every login brings rewarding progress. An exclusive MVP Dungeon system also allows players to challenge bosses without competing for monsters, meaning even solo players can farm MVP bosses freely and grow quickly without any pressure!

Transform into Heroes, Back in RO to Be the BOSS

MVP monsters such as Angeling and Deviling have also evolved into powerful Hero forms with mythic strength. Through this transformation system, players can break their limits and become legendary heroes, experiencing combat from a completely new perspective. Unleash devastating abilities and wield world-shattering skills, becoming a true legend in the adventure world.

CBT Now Available, More Pre-registration Rewards Coming Soon The limited CBT for Ragnarok: Twilight Global CBT is now open! Novices, let’s go on adventures together! Pre-registration will also launch soon. For more information about the game and its gameplay system, please follow the official Ragnarok: Twilight Global Official Facebook page. Upcoming events will offer a variety of rewards, including limited mounts, rare outfits, exclusive wings, Amazon gift cards, and other lavish prizes.

Android CBT Download : https://rotl.onelink.me/23Pu/tnq0aelh

Official Facebook: https://rotl.onelink.me/HtQJ/tjemd5b0

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

By
Advertorial Desk
-
  • Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency
  • Delivered Non-GAAP Operating Profitability in Both Q4’25 and FY’25
  • Generated Positive Operating Cash Flow for Both Q4’25 and FY’25
  • Continued Gross Profit Margin Expansion for B2B Business in Both Q4’25 and FY’25

SHANGHAI, April 9, 2026 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.

2025 Executing Strategic Optimization: Embraces Asset-Light Partnership Network Growth

In 2025, the Company proactively implemented strategic structural optimization by divesting its 100% equity interests in several subsidiaries. While this structural optimization created a temporary headwind for top-line revenue, these facilities have now joined our ecosystem as fulfillment partners and are dedicated to serving our customers exclusively. Through the divestiture of these entities and our transition to a warehouse partnership model—where we generate recurring commission income rather than bearing the operational and capital burdens—we have successfully driven continued margin expansion. By optimizing our network and selectively exiting underperforming fulfillment centers, we have strengthened our ability to further improve our profitability and liquidity profile in the future.

Fourth Quarter 2025 Highlights

  • Net revenues were RMB2.8 billion (US$403.3 million) and gross segment profit (1) was RMB164.9 million (US$23.6 million). Due to the strategic optimization, gross margin continued to expand. B2B gross profit margin reached 5.6%, representing an improvement of 60 basis points from 5.0% in the same quarter of 2024.
  • Total operating expenses were RMB165.2 million (US$23.6 million), representing a decrease of 21.3% compared to RMB209.8 million in the same quarter of 2024, highlighting continued cost optimization and efficiency gains.
  • Non-GAAP income from operations (2) was RMB0.2 million (US$0.03 million), compared to a non-GAAP loss from operations of RMB2.3 million in the same quarter of 2024. The Company achieved non-GAAP operating profitability in the quarter, marking a year-over-year turnaround from loss to profit.
  • Net cash provided by operating activities was RMB29.9 million (US$4.3 million). The Company achieved a meaningful operating cash flow turnaround, moving from negative to positive year-over-year, underscoring stronger business fundamentals and improved financial health.

Fiscal Year 2025 Highlights

  • Net revenues were RMB12.6 billion (US$1.8 billion) and gross segment profit was RMB723.4 million (US$103.4 million). Due to the strategic optimization, B2B gross profit margin rose 10 basis points from 5.4% to 5.5% year-over-year, reflecting continued optimization of core operations.
  • Total operating expenses were RMB725.8 million (US$103.8 million), representing a decrease of 12.3% compared to RMB827.1 million in the prior year. The Company continued to focus on operational efficiency and disciplined cost management.
  • Non-GAAP income from operations was RMB7.7 million (US$1.1 million), compared to RMB22.3 million in 2024. The year-over-year decrease reflected the intentional reduction in revenue scale resulting from the strategic transition, partially offset by continued gross margin expansion. Importantly, the Company maintained non-GAAP operating profitability for both 2025 and 2024, marking a key milestone on the path toward sustainable earnings.
  • Net cash provided by operating activities was RMB119.1 million (US$17.0 million). The Company delivered annual positive operating cash flow for both 2025 and 2024, demonstrating improved financial discipline and business quality.
  • Cash and cash equivalents, restricted cash and short-term investments amounted to RMB611.3 million (US$87.4 million) as of December 31, 2025, representing an increase of 17.9% compared to the end of 2024.

(1) Gross segment profit represents net revenues less cost of goods sold.

(2) Non-GAAP income (loss) from operations represents income (loss) from operations excluding share-based compensation expenses.

Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, commented, “2025 marked a pivotal year for 111, as we steadily advanced our transition to a warehouse partnership model and achieved a key profitability milestone. We delivered non-GAAP operating profitability and positive operating cash flow for both the quarter and the full year. These results underscore the strength of our platform and validate the strategic direction we have set for the Company.”

“In 2025, we proactively implemented strategic structural optimization by divesting 100% equity interests in several subsidiaries. Through the divestiture of these entities and our transition to a warehouse partnership model—where we generate recurring commission income rather than bearing operational and capital burdens—we achieved sustained gross margin expansion for the B2B business. We believe this initiative reinforces our focus on pursuing asset-light, profitable growth, strengthening our ability to scale the warehouse partnership network efficiently while maintaining a healthier financial structure.”

“Our strategic initiatives are yielding significant results. Promotional products are rapidly reaching pharmacies nationwide through the 111 digital marketing platform. Revenue from all marketing-promoted products increased by 76.2% and gross profit rose 81.7% compared to the same quarter last year. As a notable promotional product, “Cravit” has become our flagship star product, whose monthly sales volume rose sharply from 20,000 boxes at launch in March to a monthly peak of 290,000 boxes in November 2025. GMV generated by the product in 2025 also increased by 368.2% on a year-over-year basis. This success underscores our unique marketing capabilities and has delivered strong momentum to both our upstream and downstream partners.”

“Looking ahead, with our solid foundation and strategic optimization, we are well positioned for sustainable, high-quality growth. We have deeply integrated AI applications across our operations to drive meaningfully enhanced efficiency, and will continue to focus on leading the Company’s evolution from a digital to an intelligent ecosystem—creating durable long-term opportunities for our partners, customers, and shareholders. Through a more streamlined and intelligent operating model, we aim to drive consistent margin expansion, improve profitability, and deliver enduring value to all stakeholders.”

Fourth Quarter 2025 Financial Results

Net revenues were RMB2.8 billion (US$403.3 million), representing a decrease of 26.7% from RMB3.8 billion in the same quarter of 2024.

(In thousands RMB)

For the three months ended
December 31,

2024

2025

YoY

B2B Net Revenue

Product

3,759,824

2,742,449

-27.1 %

Service

21,771

21,721

-0.2 %

Sub-Total

3,781,595

2,764,170

-26.9 %

Cost of Products Sold (3)

3,592,588

2,609,356

-27.4 %

Segment Profit

189,007

154,814

-18.1 %

Segment Profit %

5.0 %

5.6 %

(In thousands RMB)

For the three months ended
December 31,

2024

2025

YoY

B2C Net Revenue

Product

62,480

53,027

-15.1 %

Service

3,700

2,967

-19.8 %

Sub-Total

66,180

55,994

-15.4 %

Cost of Products Sold

52,705

45,912

-12.9 %

Segment Profit

13,475

10,082

-25.2 %

Segment Profit %

20.4 %

18.0 %

(3) For segment reporting purposes, purchase rebates are allocated to the B2B segment and B2C segments primarily based on the amount of cost of products sold for each segment. Cost of products sold does not include other direct costs related to cost of product sales such as shipping and handling expense, payroll and benefits of logistic staff, logistic centers rental expenses and depreciation expenses, which are recorded in the fulfillment expenses.

Operating costs and expenses were RMB2.8 billion (US$403.3 million), representing a decrease of 26.8% from RMB3.9 billion in the same quarter of 2024.

  • Cost of products sold was RMB2.7 billion (US$379.7 million), representing a decrease of 27.2% from RMB3.6 billion in the same quarter of 2024.
     
  • Fulfillment expenses were RMB74.1 million (US$10.6 million), representing a decrease of 29.1% from RMB104.5 million in the same quarter of 2024. Fulfillment expenses accounted for 2.6% of net revenues this quarter as compared to 2.7% in the same quarter of 2024.
     
  • Selling and marketing expenses were RMB62.7 million (US$9.0 million), representing a decrease of 17.6% from RMB76.2 million in the same quarter of 2024. Excluding the share-based compensation expenses of RMB0.6 million for the quarter and RMB1.8 million for the same quarter of 2024, respectively, selling and marketing expenses as a percentage of net revenues accounted for 2.2% in the quarter as compared to 1.9% in the same quarter of 2024.
     
  • General and administrative expenses were RMB18.0 million (US$2.6 million), representing a decrease of 10.6% from RMB20.2 million in the same quarter of 2024. Excluding the share-based compensation expenses, general and administrative expenses as a percentage of net revenues accounted for 0.6% in the quarter as compared to 0.5% in the same quarter of 2024.
     
  • Technology expenses were RMB14.8 million (US$2.1 million), representing a decrease of 4.2% from RMB15.4 million in the same quarter of 2024. Excluding the share-based compensation expenses of RMB0.1 million for the quarter and RMB1.0 million for the same quarter 2024, respectively, technology expenses as a percentage of net revenues accounted for 0.5% in the quarter as compared to 0.4% in the same quarter of 2024.

Loss from operations was RMB0.3 million (US$0.05 million), representing a significant 95.6% narrowing compared to a loss of RMB7.3 million in the same quarter of 2024. As a percentage of net revenues, loss from operations accounted for 0.01% in the quarter, down from 0.2% in the same quarter of 2024.

Non-GAAP income from operations was RMB0.2 million (US$0.03 million), compared to a non-GAAP loss from operations of RMB2.3 million in the same quarter of 2024, marking a year-over-year turnaround from loss to profit.

Net loss was RMB6.5 million (US$0.9 million), representing an improvement of 48.3% from RMB12.5 million in the same quarter of 2024. As a percentage of net revenues, net loss accounted for 0.2% in the quarter, down from 0.3% in the same quarter of 2024.

Non-GAAP net loss (4) was RMB5.9 million (US$0.9 million), representing an improvement of 20.9% from RMB7.5 million in the same quarter of 2024. As a percentage of net revenues, non-GAAP net loss accounted for 0.2% in the quarter, consistent with the same period last year.

Net loss attributable to ordinary shareholders was RMB16.2 million (US$2.3 million), representing an improvement of 18.2% from RMB19.8 million in the same quarter of 2024. As a percentage of net revenues, net loss attributable to ordinary shareholders accounted for 0.6% in the quarter as compared to 0.5% in the same quarter of 2024.

Non-GAAP net loss attributable to ordinary shareholders (5) was RMB15.7 million (US$2.2 million), compared to RMB14.8 million in the same quarter of last year. As a percentage of net revenues, non-GAAP net loss attributable to ordinary shareholders accounted for 0.6% in the quarter as compared to 0.4% in the same quarter of 2024.

(4) Non-GAAP net loss represents net loss excluding share-based compensation expenses, net of tax. Considering the impact of accretion of redeemable non-controlling interest for the fourth quarter and fiscal year ended December 31, 2025, non-GAAP net loss is used as a meaningful measurement of the operation performance of the Company.

(5) Non-GAAP net loss attributable to ordinary shareholders represents net loss attributable to ordinary shareholders excluding share-based compensation expenses, net of tax.

Fiscal Year 2025 Financial Results

Net revenues were RMB12.6 billion (US$1.8 billion), representing a decrease of 12.8% from RMB14.4 billion in the previous year.

(In thousands RMB)

For the year ended December 31,

2024

2025

YoY

B2B Net Revenue

Product

14,033,543

12,247,430

-12.7 %

Service

89,609

73,775

-17.7 %

Sub-Total

14,123,152

12,321,205

-12.8 %

Cost of Products Sold

13,357,617

11,641,681

-12.8 %

Segment Profit

765,535

679,524

-11.2 %

Segment Profit %

5.4 %

5.5 %

(In thousands RMB)

For the year ended December 31,

2024

2025

YoY

B2C Net Revenue

Product

261,197

223,217

-14.5 %

Service

16,900

11,601

-31.4 %

Sub-Total

278,097

234,818

-15.6 %

Cost of Products Sold

214,403

190,936

-10.9 %

Segment Profit

63,694

43,882

-31.1 %

Segment Profit %

22.9 %

18.7 %

 

Operating costs and expenses were RMB12.6 billion (US$1.8 billion), representing a decrease of 12.8% from RMB14.4 billion in 2024.

  • Cost of products sold was RMB11.8 billion (US$1.7 billion), representing a decrease of 12.8% from RMB13.6 billion in 2024.
     
  • Fulfillment expenses were RMB345.2 million (US$49.4 million), representing a decrease of 9.4% from RMB381.0 million in 2024. Fulfillment expenses accounted for 2.7% of net revenues in 2025 as compared to 2.6% in 2024.
     
  • Selling and marketing expenses were RMB258.6 million (US$37.0 million), representing a decrease of 17.6% from RMB313.9 million in the previous year. Excluding the share-based compensation expenses of RMB4.0 million for 2025 and RMB6.9 million for 2024, respectively, selling and marketing expenses as a percentage of net revenues, decreased to 2.0% in 2025 from 2.1% in 2024.
     
  • General and administrative expenses were RMB69.5 million (US$9.9 million), representing a decrease of 2.0% from RMB70.9 million in 2024. Excluding the share-based compensation expenses of RMB4.9 million for 2025 and RMB9.2 million for 2024, respectively, general and administrative expenses accounted for 0.5% of net revenues in 2025 as compared to 0.4% in 2024.
     
  • Technology expenses were RMB60.4 million (US$8.6 million), representing a decrease of 13.3% from RMB69.6 million in 2024. Excluding the share-based compensation expenses of RMB1.1 million for 2025 and RMB4.0 million for 2024, respectively, technology expenses accounted for 0.5% of net revenues in 2025, maintaining the same percentage as 2024.

Loss from operations was RMB2.4 million (US$0.3 million), compared to income from operations of RMB2.1 million in 2024.

Non-GAAP income from operations was RMB7.7 million (US$1.1 million), compared to RMB22.3 million in 2024. As a percentage of net revenues, non-GAAP income from operations accounted for 0.1% in 2025 as compared to 0.2% in 2024.

Net loss was RMB22.5 million (US$3.2 million), compared to RMB20.8 million in 2024. As a percentage of net revenues, net loss accounted for 0.2% in 2025 as compared to 0.1% in 2024.

Non-GAAP net loss was RMB12.5 million (US$1.8 million), compared to RMB0.6 million in 2024. As a percentage of net revenues, non-GAAP net loss accounted for 0.1% in 2025 as compared to 0.004% in 2024.

Net loss attributable to ordinary shareholders was RMB66.4 million (US$9.5 million), compared to RMB64.7 million in 2024. As a percentage of net revenues, net loss attributable to ordinary shareholders accounted for 0.5% in 2025 as compared to 0.4% in 2024.

Non-GAAP net loss attributable to ordinary shareholders was RMB56.3 million (US$8.1 million), compared to RMB44.6 million in 2024.  As a percentage of net revenues, non-GAAP net loss attributable to ordinary shareholders accounted for 0.4% in 2025, up from 0.3% in 2024.

As of December 31, 2025, the Company held cash and cash equivalents, restricted cash and short-term investments totaling RMB611.3 million (US$87.4 million), compared to RMB518.3 million as of December 31, 2024. To date, amount of RMB1.12 billion has been included in the balances of redeemable non-controlling interests and accrued expenses and other current liabilities. This amount is owed to a group of investors of 1 Pharmacy Technology pursuant to equity investments made in 2020, as previously disclosed. 111 has received redemption requests from certain of such investors in accordance with the terms of their initial investments in 1 Pharmacy Technology. Following communication and negotiation, the Company has further reached agreements with, or received commitment letters from, all investors to reschedule the repayments, allowing for phased repayments at extended periods, if the investors exercise their redemption rights. In February 2026, the Company made repayments of approximately RMB189.0 million (US$27.0 million) to all investors of 1 Pharmacy Technology. For further details about such investors’ investments in 1 Pharmacy Technology, please see “Item 4. Information on the Company-A. History and Development of the Company” in the Company’s annual report for the fiscal year ended December 31, 2024.

Use of Non-GAAP Financial Measures

In evaluating the business, the Company considers and uses non-GAAP income (loss) from operations, non-GAAP net loss, non-GAAP net loss attributable to ordinary shareholders, and non-GAAP loss per ADS, as supplemental measures to review and assess its operating performance. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding share-based compensation expenses. The Company defines non-GAAP net loss as net loss excluding share-based compensation expenses, net of tax. The Company defines non-GAAP net loss attributable to ordinary shareholders as net loss attributable to ordinary shareholders excluding share-based compensation expenses, net of tax. The Company defines non-GAAP loss per ADS as net loss attributable to ordinary shareholders per ADS excluding share-based compensation expenses, net of tax per ADS. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP.

The Company believes that non-GAAP income (loss) from operations, non-GAAP net loss, non-GAAP net loss attributable to ordinary shareholders, and non-GAAP loss per ADS help identify underlying trends in its business that could otherwise be distorted by the effect of certain expenses that it includes in income (loss) from operations and net loss. Share-based compensation expenses is a non-cash expense that varies from period to period. As a result, management excludes the items from its internal operating forecasts and models. Management believes that the adjustments for share-based compensation expenses provide investors with a reasonable basis to measure the company’s core operating performance, in a more meaningful comparison with the performance of other companies. The Company believes that non-GAAP income (loss) from operations, non-GAAP net loss, non-GAAP net loss attributable to ordinary shareholders, and non-GAAP loss per ADS provide useful information about its operating results, enhances the overall understanding of its past performance and future prospects and allow for greater visibility with respect to key metrics used by the management in their financial and operational decision-making.

The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools. One of the key limitations of using non-GAAP income (loss) from operations, non-GAAP net loss, non-GAAP net loss attributable to ordinary shareholders, or non-GAAP loss per ADS is that it does not reflect all items of income and expense that affect the Company’s operations. Further, the non-GAAP financial measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited.

The Company compensates for these limitations by reconciling the non-GAAP financial measures to the most comparable U.S. GAAP measures, all of which should be considered when evaluating the Company’s performance. The Company encourages you to review its financial information in its entirety and not rely on a single financial measure.

Reconciliation of the non-GAAP financial measures to the most comparable U.S. GAAP measures is included at the end of this press release.

Exchange Rate Information Statement

This announcement contains translations of certain RMB amounts into U.S. dollars at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars are made at a rate of RMB6.9931 to US$1.00, the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of December 31, 2025.

Forward-Looking Statements

This press release contains forward-looking statements. These statements constitute “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “confident” and similar statements. Among other things, the Business Outlook and quotations from management in this announcement, as well as 111’s strategic and operational plans, contain forward-looking statements. 111 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company’s ability comply with extensive and evolving regulatory requirements, its ability to compete effectively in the evolving PRC general health and wellness market, its ability to manage the growth of its business and expansion plans, its ability to achieve or maintain profitability in the future, its ability to control the risks associated with its pharmaceutical retail and wholesale businesses, and the Company’s ability to meet the standards necessary to maintain listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq’s continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and 111 does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company’s online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.

For more information on 111, please visit: http://ir.111.com.cn/.

For more information, please contact:

111, Inc. 
Investor Relations 
Email: ir@111.com.cn 

111, Inc. 
Media Relations 
Email: press@111.com.cn
Phone: +86-021-2053 6666 (China)

 

111, Inc.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except for share and per share data)

As of

As of

December 31, 2024

December 31, 2025

RMB

RMB

US$

ASSETS

Current assets:

Cash and cash equivalents

462,289

510,967

73,067

Restricted cash

56,043

50,337

7,198

Short-term investments

–

50,031

7,154

Accounts receivable, net 

413,101

259,686

37,135

Notes receivable

78,827

58,617

8,382

Inventories

1,387,403

998,465

142,779

Prepayments and other current assets

251,994

196,756

28,136

Total current assets

2,649,657

2,124,859

303,851

Property and equipment, net

32,903

21,108

3,018

Intangible assets, net

1,437

868

124

Long-term investments

–

–

–

Other non-current assets

14,682

9,285

1,328

Operating lease right-of-use assets

89,071

44,122

6,309

Total assets

2,787,750

2,200,242

314,630

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ DEFICIT

Current liabilities:

Short-term borrowings

160,981

187,631

26,831

Accounts payable

1,721,425

1,282,368

183,376

Accrued expense and other current liabilities

460,173

483,676

69,164

Total current liabilities

2,342,579

1,953,675

279,371

Long-term operating lease liabilities

55,448

29,965

4,285

Other non-current liabilities

8,961

2,181

312

Total liabilities

2,406,988

1,985,821

283,968

MEZZANINE EQUITY

Redeemable non-controlling interests

1,038,914

935,917

133,834

SHAREHOLDERS’ DEFICIT

Ordinary shares Class A

33

34

5

Ordinary shares Class B

25

25

3

Treasury shares

(5,887)

(5,887)

(842)

Additional paid-in capital

3,172,820

3,181,343

454,926

Accumulated deficit

(3,883,992)

(3,950,384)

(564,897)

Accumulated other comprehensive income

74,357

72,635

10,387

Total shareholders’ deficit

(642,644)

(702,234)

(100,418)

Non-controlling interest

(15,508)

(19,262)

(2,754)

Total deficit

(658,152)

(721,496)

(103,172)

Total liabilities, mezzanine equity and deficit

2,787,750

2,200,242

314,630

 

 

111, Inc.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 (In thousands, except for share and per share data)

For the three months ended December 31,

For the year ended December 31,

2024

2025

2024

2025

RMB

RMB

US$

RMB

RMB

US$

Net revenues

3,847,775

2,820,164

403,278

14,401,249

12,556,023

1,795,488

Operating costs and expenses:

 Cost of products sold

(3,645,293)

(2,655,268)

(379,698)

(13,572,020)

(11,832,617)

(1,692,042)

 Fulfillment expenses

(104,476)

(74,058)

(10,590)

(381,035)

(345,222)

(49,366)

 Selling and marketing expenses

(76,173)

(62,746)

(8,973)

(313,897)

(258,643)

(36,985)

 General and administrative expenses

(20,160)

(18,031)

(2,578)

(70,907)

(69,459)

(9,933)

 Technology expenses

(15,410)

(14,769)

(2,112)

(69,635)

(60,391)

(8,636)

 Other operating income, net

6,418

4,387

627

8,359

7,932

1,134

Total operating costs and expenses

(3,855,094)

(2,820,485)

(403,324)

(14,399,135)

(12,558,400)

(1,795,828)

(Loss) Income from operations

(7,319)

(321)

(46)

2,114

(2,377)

(340)

 Interest income

1,467

932

133

7,041

3,885

556

 Interest expense

(5,264)

(11,329)

(1,620)

(28,331)

(35,572)

(5,087)

 Foreign exchange (loss) gain

(949)

190

27

(909)

480

69

 Other (loss) income, net

(479)

4,039

578

(595)

11,082

1,585

Loss before income taxes

(12,544)

(6,489)

(928)

(20,680)

(22,502)

(3,217)

 Income tax expense

(3)

–

–

(96)

(13)

(2)

Net loss

(12,547)

(6,489)

(928)

(20,776)

(22,515)

(3,219)

Net loss attributable to non-controlling interest

8,829

209

30

8,398

4,094

585

Net loss attributable to redeemable non-controlling interest

824

316

45

1,992

1,106

158

Adjustment attributable to redeemable non-controlling interest

(16,947)

(10,257)

(1,467)

(54,357)

(49,077)

(7,018)

Net loss attributable to ordinary shareholders

(19,841)

(16,221)

(2,320)

(64,743)

(66,392)

(9,494)

Other comprehensive loss

 Unrealized (loss) gain of available-for-sale securities,

(320)

677

97

1,074

677

97

 Realized gain (loss) of available-for-sale debt securities

321

(646)

(92)

(1,217)

(646)

(92)

 Foreign currency translation adjustments

1,754

(441)

(63)

1,986

(1,753)

(251)

Comprehensive loss

(18,086)

(16,631)

(2,378)

(62,900)

(68,114)

(9,740)

Loss per ADS:

 Basic and diluted

(2.20)

(1.80)

(0.20)

(7.60)

(7.60)

(1.00)

Weighted average number of shares used in computation of loss per share

 Basic and diluted

172,757,611

175,251,218

175,251,218

171,835,632

174,026,392

174,026,392

 

 

111, Inc.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 (In thousands)

For the three months ended December 31,

For the year ended December 31,

2024

2025

2024

2025

RMB

RMB

US$

RMB

RMB

US$

Net cash (used in) provided by operating activities 

(48,547)

29,871

4,271

263,016

119,142

17,036

Net cash provided by (used in) investing activities 

37,517

(22,438)

(3,208)

37,376

(53,723)

(7,681)

Net cash (used in) provided by financing activities

(35,783)

26,561

3,797

(406,236)

(21,194)

(3,031)

Effect of exchange rate changes on cash and cash equivalents, and restricted cash

734

(239)

(34)

628

(1,253)

(179)

Net (decrease) increase in cash and cash equivalents, and restricted cash

(46,079)

33,755

4,826

(105,216)

42,972

6,145

Cash and cash equivalents, and restricted cash at the beginning of the period

564,411

527,549

75,439

623,548

518,332

74,120

Cash and cash equivalents, and restricted cash at the end of the period

518,332

561,304

80,265

518,332

561,304

80,265

 

 

 111, Inc.

Unaudited Reconciliation of GAAP and Non-GAAP Results

 (In thousands, except for share and per share data)

For the three months ended December 31,

For the year ended December 31,

2024

2025

2024

2025

RMB

RMB

US$

RMB

RMB

US$

(Loss) Income from operations

(7,319)

(321)

(46)

2,114

(2,377)

(340)

Add: Share-based compensation expenses

5,027

544

78

20,149

10,047

1,437

Non-GAAP (loss) income from operations

(2,292)

223

32

22,263

7,670

1,097

Net loss

(12,547)

(6,489)

(928)

(20,776)

(22,515)

(3,219)

Add: Share-based compensation expenses, net of tax

5,027

544

78

20,149

10,047

1,437

Non-GAAP net loss

(7,520)

(5,945)

(850)

(627)

(12,468)

(1,782)

Net loss attributable to ordinary shareholders

(19,841)

(16,221)

(2,320)

(64,743)

(66,392)

(9,494)

Add: Share-based compensation expenses, net of tax

5,027

544

78

20,149

10,047

1,437

Non-GAAP net loss attributable to ordinary shareholders

(14,814)

(15,677)

(2,242)

(44,594)

(56,345)

(8,057)

Loss per ADS (6): Basic and diluted

(2.20)

(1.80)

(0.20)

(7.60)

(7.60)

(1.00)

Add: Share-based compensation expenses per ADS (6), net of tax

0.60

0.00

0.00

2.40

1.20

0.20

Non-GAAP loss per ADS (6)

(1.60)

(1.80)

(0.20)

(5.20)

(6.40)

(0.80)

(6) Every one ADS represents twenty Class A ordinary shares. 

 

i2Cool Launches 4th Anniversary Global Tour in Vietnam, Expanding Electricity-free Cooling Across Industry and Community Applications

By
Advertorial Desk
-

HONG KONG and HO CHI MINH CITY, Vietnam, April 9, 2026 /PRNewswire/ — i2Cool, a pioneer in electricity-free cooling technology, has officially launched its 4th anniversary global tour under the theme “4ward Thinking, 4ward Cooling”, with Vietnam as the first stop. The multi-city initiative highlights the company’s latest technological developments, expanding global partnerships, and real-world applications across both commercial and community settings.

Originating from the City University of Hong Kong under the HK Tech 300 programme in 2021, i2Cool has developed a material-based passive cooling solution inspired by the Saharan silver ant. By combining high solar reflectivity and mid-infrared emissivity, the technology enables surface cooling without electricity consumption or refrigerants.

To date, i2Cool’s solutions have been deployed in more than 500 projects across nearly 30 countries and regions, supporting energy efficiency and carbon reduction in sectors including construction, industry, logistics, and agriculture.


Three-City Programme in Vietnam Marks First Phase of Global Roadshow

The Vietnam programme, organized in collaboration with local partner APOLLO, spans three cities—Haiphong, Hanoi, and Ho Chi Minh City—offering a comprehensive engagement from industry dialogue to real-world application.

Haiphong: Industry Salon and Technology Exchange

The tour officially commenced on March 24 in Haiphong with a 4th anniversary salon and investment exchange session held at Taiyo Building.

During the session, i2Cool Co-founder and CEO, Pro.Martin Zhu, presented the scientific foundation of electricity-free cooling technology, including its biomimetic origins and material-based heat management mechanism. He also shared application cases across building rooftops, glass façades, photovoltaic systems, and cold-chain logistics, demonstrating measurable temperature reduction and energy-saving potential.

A key highlight of the event was the introduction of i2Cool’s electricity-free cooling nano-particle. Unlike conventional coatings or films, i2nano-particle can be integrated into plastics, rubber, and textile materials, enabling passive cooling at the material level. The launch prompted discussions among local stakeholders on potential localization and industrial applications in Vietnam.

Representatives from APOLLO noted that Vietnam’s tropical climate and rapid urbanization are driving increasing demand for energy-efficient cooling solutions, particularly in construction, industrial storage, and logistics sectors.

Hanoi: Industry Engagement at VIETBUILD 2026

Following Haiphong, i2Cool participated in VIETBUILD 2026, held from March 26 to 30 at the Vietnam Exhibition Center (VEC) in Hanoi.

At Booth H1-061, i2Cool and APOLLO jointly showcased a full range of electricity-free cooling solutions, including coatings, films, membranes, and textile applications. The booth attracted developers, contractors, and engineers, with on-site consultations addressing localized challenges such as high humidity and solar heat gain.

The exhibition provided a platform for in-depth exchange on how passive cooling materials can be adapted to tropical climates, supporting both energy efficiency and indoor comfort.

Ho Chi Minh City: Community Deployment in Real-World Conditions

The Vietnam programme concluded with a community initiative in Ho Chi Minh City, where i2Cool implemented its electricity-free cooling coating at an elderly care facility in Tu Hanh Buddhist Temple.

Unlike controlled demonstration settings, the application was carried out in an actively used environment. Within a single morning, the team completed on-site coating using a multi-layer system, covering areas exposed to prolonged sunlight and poor ventilation.

The project addressed a common challenge in such facilities: uneven cooling coverage and high operational costs associated with air conditioning. By reducing heat gain at the building surface, the solution helps improve indoor thermal conditions while lowering reliance on continuous energy consumption.

The initiative also included collaboration with local volunteers and partners, ensuring smooth implementation and laying the foundation for post-application monitoring and feedback.

Global Roadmap and Market Outlook

The Vietnam tour marks the beginning of i2Cool’s broader anniversary programme, with upcoming stops planned in Thailand, Hong Kong, Shanghai, and Shenzhen.

In addition to product demonstrations, the tour introduces global partnership frameworks, distribution opportunities, and insights into material-based cooling technologies under different climate conditions.

According to industry analysis by QYResearch, the global passive cooling market is expected to grow at a compound annual growth rate exceeding 26%, driven by rising demand for energy-efficient cooling solutions.

About i2Cool

i2Cool is a climate technology company specializing in electricity-free cooling solutions. Originating from the City University of Hong Kong, the company develops advanced materials that enable passive radiative cooling.

Its product portfolio includes coatings, films, membranes, textiles, and nano-particle materials, serving applications across construction, industrial facilities, logistics, agriculture, and consumer products.

With operations across Hong Kong and mainland China, and projects spanning nearly 30 countries and regions, i2Cool continues to advance sustainable cooling technologies for a low-carbon future.

Contact: Rachel Huang, rachel.huang@i2cool.com 

Chinese Mainland’s Largest Conference on Chest Pain Centres Goes Global in Hong Kong

By
Advertorial Desk
-

With robust lineup of medical conventions in 2026


HONG KONG SAR – Media OutReach Newswire – 9 April 2026 – Marking yet another milestone as the World’s Meeting Place, Hong Kong became the first city outside Chinese Mainland to host the nation’s largest conference on chest pain centres – the 15th China Chest Pain Centers Congress (CCPCC 2026), thanks to the effort of Hong Kong Convention Ambassador (HKCA) appointed by the Hong Kong Tourism Board (HKTB).

The 15th China Chest Pain Centers Congress

The 15th China Chest Pain Centers Congress

Together with two other high-profile and hugely successful medical congresses – the 41st Asia Pacific Academy of Ophthalmology Congress in February and the 17th Asian Congress of Oral & Maxillofacial Surgery in March, Hong Kong’s medical science events space was off to a strong start in 2026.

Ms Marilyn Tham, General Manager of Mega Events, MICE & Cruise of the HKTB said, “Hong Kong’s leading edge in medical sciences coupled with the city’s world-class venues and destination appeal have enabled notable success for internationally significant medical events. CCPCC 2026 is one of the large-scale medical conventions confirmed for 2026. Such robust lineup reflects event organisers’ confidence in Hong Kong as a premier hub for advancing global exchanges on medical sciences.”

Over 10 medical conventions have secured a spot in Hong Kong this year, spanning diverse disciplines, from cytology to oncology, antimicrobial resistance and more (see full list below). The breadth and depth of the events reflects Hong Kong’s growing appeal as the premier convention hub where global medical minds meet.

Globalising Chest Pain Leadership from Hong Kong

Held on 3-4 April 2026 at the Hong Kong Convention and Exhibition Centre with a concurrent venue in Shenzhen, CCPCC 2026 converged 3,000 healthcare leaders, physicians, nurses, researchers, policymakers and industry experts from Hong Kong, Chinese Mainland, the Belt and Road countries and beyond. The rich topics explored across two days encompassed cutting-edge healthcare innovations, AI-assisted clinical decision-making, intelligent emergency response systems and international accreditation standards.

Co-organised by Hospital Authority (HA) of Hong Kong, the National Clinical Research Center for Interventional Medicine, the Guangdong Chest Pain Centers Association, the Chinese Cardiovascular Association (CCA) and Oriental Huaxia Cardiovascular Health Research Institute (OHCHRI), Suzhou Industrial Park, CCPCC 2026 showcased conducive partnership.

Mr. Wenming Zeng, Secretary-General of OHCHRI, remarked, “The global influence of CCPCC has been growing over the years. Thanks to Hong Kong’s strategic location, leading medical standing and its unique role bridging Chinese Mainland and the world, this year’s congress has drawn even wider global participation, giving the event greater international significance. Hong Kong has helped showcase our event to the world, taking cardiovascular emergency intervention to a new height globally.”

Mr. Wenming Zeng, Secretary-General of OHCHRI

A Launchpad for Mainland-spearheaded International Standards

Capitalising on Hong Kong’s strengths as a super-connector for fostering globalisation, CCPCC 2026 released for the first time the “International Standards on Chest Pain Center Construction and Accreditation”, marking Mainland’s global leadership in cutting-edge cardiovascular emergency intervention. Leveraging Hong Kong’s internationalisation, the efforts to foster global policy support and implementation of the standards will contribute to fair, accessible and timely intervention for cardiovascular emergencies around the world.

Another Significant Win for HKCA Programme on its 5th Anniversary

Hong Kong Convention Ambassador Networking Cocktail 2026

Hong Kong Convention Ambassador Networking Cocktail 2026

Hong Kong Convention Ambassador Networking Cocktail 2026

As a HKTB-appointed HKCA, Prof Lu Shi-Juan, who is a Member of Hainan Medical Association Cardiovascular Professional Committee, played an instrumental role in bringing CCPCC 2026 to Hong Kong. This marked the latest success story of the HKCA programme, as HKTB celebrated the programme’s milestone 5th anniversary with a HKCA Networking Cocktail Event on 31 March, 2026.

Prof Lu noted, “As a Hong Kong International Convention Ambassador, I have worked closely with the HKTB to bring CCPCC to Hong Kong, which is a gateway to the global stage. Hosting the conference here showcases how Hong Kong can elevate Mainland conferences internationally, foster cross‑border knowledge exchange and help shape the future development of the broader medical and professional community.”

Prof Lu Shi-Juan, Committee Member of Hainan Medical Association Cardiovascular Professional Committee

The HKCA programme bands together over 170 local and mainland sector leaders of 13 industries and academics to champion Hong Kong as the World’s Meeting Place. Their initiative and connections have helped Hong Kong secure 50 convention wins that have brought in nearly 100,000 high-value overnight MICE visitors.

Strong Medical Events Lineup in 2026

Over 10 medical conventions will be held in 2026 across various disciplines, including ophthalmology, oncology, antimicrobial resistance and cytology.

Event

(*first-ever in Hong Kong)

Date / Venue Highlights
The 41st Asia-Pacific Academy of Ophthalmology Congress 2026 5-8 Feb,

HKCEC

The largest and most authoritative ophthalmology congress in APAC, returning to HK for the fifth time, with record-breakingattendance of 11,000+ participants from 111 countries and regions.
The 17th Asian Congress on Oral and Maxillofacial Surgery 2026 27-29 Mar,

HKCEC

Held in Hong Kong for the second time, bringing together internationally acclaimed speakers, globally renowned experts and young surgeons to foster academic exchange and professional development.
The 15th China Chest Pain Centers Congress 3-4 Apr,

HKCEC

Chinese Mainland’s largest conference on chest pain centres, hosted for the first time outside Chinese Mainland.
*Asian Federation of Cytology Societies Conference 2026 8-10 May,

Postgraduate Education Centre, Prince of Wales Hospital

First edition in Hong Kong, bringing together regional and international cytology experts for academic exchange and collaboration.
International Symposium on Antimicrobial Agents and Resistance 2026 12-14 Jun,

HKCEC

A key international platform for academic exchange on infectious diseases and antimicrobial resistance.
European Society of Medical Oncology Targeted Anticancer Therapies Asia 2026 12-14 Jun,

Kerry Hotel

A key Asia-Pacific platform for showcasing the latest advances in early-phase oncology drug development, targeted therapies and precision oncology.
Federation of Asian and Oceanian Biochemists and Molecular Biologists Conference 2026 10-13 Aug,

Cheung Kung Hai Conference Centre, The University of Hong Kong

A major regional scientific meeting in biochemistry and molecular biology, bringing together researchers, educators and professionals from across Asia and Oceania for academic exchange and collaboration.
* 2026 World Cancer Congress 24-26 Sep,

HKCEC

A leading global forum advancing cancer control and research.
2026 Asia-Pacific Longevity Medicine International Summit 1-4 Oct,

TBC

A leading international platform and regional collaborative hub dedicated to longevity medicine and innovation, attracting top longevity scientists, medical experts, cross-industry entrepreneurs and investors from over 50 countries.
10th Asia Cornea Society Scientific Meeting 2026 11-13 Dec,

TBC

A key regional forum for cornea specialists to exchange the latest clinical insights, diagnostics and treatments, and to strengthen collaboration across the Asia-Pacific ophthalmology community.
Association of Pacific Rim Universities (APRU) Global Health Conference 2026 7-9 Dec,

Henry Cheng International Conference Centre, CUHK

Third time in Hong Kong, convening leading academics, policymakers and practitioners to address critical global health challenges through interdisciplinary collaboration and innovation.

Hashtag: #HongKongTourismBoard #MEHK #MeetingsandExhibitionsHongKong #HongKong #MICE #Medical #Convention #Conference #Event


The issuer is solely responsible for the content of this announcement.

Strict Rules Set for Upcoming Pi Mai Lao Celebrations, Officials Say

By
Phoudasack Vongsay
-
A picture of Pi Mai Lao celebration in Luang Prabang, Laos 2023. (Photo by J&C Group)

Authorities in Laos have laid out strict rules to control public behaviour during upcoming Pi Mai Lao, targeting unsafe and disruptive activities in Vientiane capital and across the country.

The ban includes the use and sale of fireworks, sky lanterns, and explosive materials nationwide, with fines may vary by location. 

In Vientiane capital, penalties range from LAK 500,000 (USD 22.77) to LAK 5 million (USD 227.77), with items subject to confiscation and destruction.

Water-related restrictions are also tightened in Vientiane Capital. Throwing dirty water, ice, or objects at people and vehicles is prohibited, as is setting up large water systems or spraying from trucks along public roads due to safety risks.

Public celebrations will face tighter control in the capital as well, according to the notice. Street dancing, setting up stalls on roads or pavements, and vehicle parades are banned unless officially approved, as authorities aim to reduce traffic congestion and accidents.

All Businesses, including restaurants, entertainment venues, and shops, must follow strict operating rules, particularly on noise levels. 

For Vientiane, sound must not exceed 80 decibels and is only allowed between 08:00 and 23:00. Repeat violations can lead to fines of up to LAK 10 million (USD 456) and equipment seizure.

Traffic laws will also be strictly enforced nationwide, with zero tolerance for drunk driving, speeding, illegal parking, and overcrowded vehicles.

Authorities also warned drivers to follow safety rules, including avoiding drunk driving, phone use, speeding over 40 km per hour in urban areas and overloading vehicles. 

Data from 2025 recorded 6,779 accidents and 917 deaths, highlighting ongoing safety concerns during the festive period.

1...617618619...6,513Page 618 of 6,513